US6024961012
US6024961012
MiMedx Group, Inc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 681.51M EUR | 561.04M EUR | 588.28M EUR | 1B EUR |
Enterprise Value | 554.78M EUR | 442.41M EUR | 446.1M EUR | 854.44M EUR |
Valuation Multiples | ||||
Trailing P/E | 116.75x | 89.92x | 19.16x | 24.13x |
Forward P/E | 23.35x | -- | -- | -- |
Price to Sales | 1.92x | 1.58x | 1.51x | 3.03x |
Price to Book | 3.15x | 2.6x | 2.42x | 3.91x |
EV/Revenue | 1.56x | 1.25x | 1.15x | 2.59x |
EV/EBITDA | 27.18x | 20.55x | 8.26x | 12.69x |
Price to FCF (P/FCF) | 16.45x | 12.63x | 8.48x | 14.73x |
EV/FCF | 13.39x | 9.96x | 6.43x | 12.56x |
FCF Yield | 6.08% | 7.92% | 11.79% | 6.79% |